
    
      PRIMARY OBJECTIVES:

      I. To evaluate the 10-year global impact of human papillomavirus (HPV)-16/18 vaccination of
      young adult women.

      II. To evaluate determinants of the immune response to HPV and the vaccine, and markers of
      long-term protection.

      III. To evaluate the natural history of HPV and cervical disease in vaccinated and
      unvaccinated populations.

      OUTLINE:

      Participants undergo long term follow-up comprising risk factor questionnaire, pelvic
      examination for all sexually experienced women, and specimen collection at years 6, 8, and
      10.
    
  